Stock Analysis of ARCA Biopharma Inc (ABIO) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ABIO
Close 3.33
Change -0.670 / 16.75 %
Volume 457274
Vol Change 282357 / 161.42 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bearish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index No Significant Stability


Fundamental View of ARCA Biopharma Inc
PE (TTM)

-2195.73

Very Poor
Price / Book

316.84

Very Poor
Price / Sales

68366.96

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

48308.64 K

Enterprise Value

10953.64 K

ROA (TTM)

-13.92

Very Poor
ROE (TTM)

-14.43

Very Poor
Net Margin (TTM)

-3113.64

Very Poor
Revenue

%

0
Net Profit

45.36 %

-5424.00 K
Debt to Equity

0.0021

Excellent
Altman Z Score

28.19

Excellent
Quick Ratio

0

Poor
Cash Ratio

58.76

Excellent


Highs/Lows of ARCA Biopharma Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week3.47 4.03 % 1.54 % 4.493.0917-May-2413-May-24
Two Week3.26 2.15 % 3.42 % 4.493.0917-May-2413-May-24
One Month3.21 3.74 % 5.60 % 4.493.0917-May-2413-May-24
Three Month1.67 99.40 % 5.95 % 4.491.5717-May-2421-Feb-24
Six Months1.81 83.98 % 17.48 % 4.491.5617-May-2419-Jan-24
One year2.11 57.82 % 27.52 % 4.491.5617-May-2419-Jan-24
Two year2.35 41.70 % 29.70 % 4.491.5617-May-2419-Jan-24
Five year9.41 64.61 % 85.46 % 4.491.5617-May-2419-Jan-24
Ten year176.4 98.11 % 182.41 % 207.91.5607-Jul-1419-Jan-24


Technical View of ARCA Biopharma Inc
RSI

51.42

Strong Bearish
MACD

0.185

Whipsaw
ADX

46.38

Mild Bullish
Super Trend

3.08

Mild Bullish
Williams %R

-82.86

Strong Bearish
CCI

85.18

Strong Bearish


EMA 5

3.55

Strong Bearish
EMA 15

3.44

Whipsaw
EMA 50

2.94

Bullish
EMA 100

2.53

Bullish
SMA 100

2.22

Bullish
SMA 200

2.08

Strong Bullish
SMA 5 / 20

3.55 / 3.45

Bullish
SMA 15 / 50

3.41 / 2.79

Bullish
SMA 50 / 200

2.79 / 2.08

Strong Bullish




Charts of ARCA Biopharma Inc


Returns of ARCA Biopharma Inc with Peers
Period / StockABIODAREAGLEDYAI
1 Week-4.03%56.30%14.38%13.80%
1 Mth3.74%71.67%12.66%-1.79%
3 Mth99.40%34.32%2196.37%25.00%
6mth83.98%41.49%8783.14%-3.51%
1 Year57.82%-52.88%868.55%-21.43%
2 Year41.70%-57.05%86.20%-29.18%
5 Years-64.61%-45.53%48.64%-60.14%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of ARCA Biopharma Inc with Peers
Ratio / StockABIODAREAGLEDYAI
PE-2195.73-1.21-976.16-6.06
P/B316.84-10.825076.186.28
ROA-13.92-127.85-221.11-72.62
ROE-14.4300-103.72
Debt To Equity0.0021-0.09300.0082
Revenue0
% 		1000000
99.99 % 		1054.00 K
54.74 % 		2898.81 K
1.07 %
Net Income-5424.00 K
45.36 % 		-41047.05 K
99.87 % 		-294432.00 K
251.29 % 		-6795.46 K
30.20 %


Technicals of ARCA Biopharma Inc with Peers
Technical / StockABIODAREAGLEDYAI-
ADX46.3821.3013.2020.47
CMF0.153-0.282-0.0095-0.256
MFI43.7091.3142.4969.66
RSI51.4270.9059.2357.82
MACD Abv SignalFalseTrueTrueTrue
Price Above 50 MATrueTrueTrueTrue-
Price Above 200 MATrueTrueTrueFalse-


About : ARCA Biopharma Inc

Address : 10170 Church Ranch Way, Westminster, CO, United States, 80021
Tel : 720 940 2200
URL : https://www.arcabio.com
Code : ABIO, ISIN : US00211Y5069, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 08_Aug_1997
Employee Count : 4

ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with heart failure. It is developing Recombinant Nematode Anticoagulant Protein c2, a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. The company has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.


Note : All Data Generated at the End of Trading Hours (EOD Data)